News
MicroPort® Appoints Greg Holman as Chief Commercial Officer
27 May 2026
® Appoints Greg Holman as Chief Commercial Officer
MicroPort Scientific Corp. on 6ix
Story so far
Earlier from MicroPort Scientific
- APOLLO Dream® Sirolimus Target Eluting Stent System Granted FDA Breakthrough Device Designation
- FDA Grants Breakthrough Device Designation to Endovastec™’s Hector™ Multi-Branch Thoracic Stent Graft System
- Toumai® Laparoscopic Surgical Robot Surpasses 200 Global Commercial Orders
- MicroPort Scientific: CardioFlow Announces Commercial Launch of FLEXIGO™ 3D delivery system for LBBAP in Europe and Australia
- MicroPort® CardioFlow and MicroPort® CRM Complete Strategic Merger: Launching a New Era in Heart Failure Treatment
Later from MicroPort Scientific
- CardioFlow Enrolls First Patients Worldwide in STARLIGHT Clinical Trial Evaluating the LINEA™ Pacing Lead for LBBAP
- ® Enters into Letter of Intent with Tinavi for Potential Disposal of International Orthopedics Business
- ® Endovastec™’s Aorfix™ Endograft System Granted NMPA Green Channel Designation for Innovative Medical Devices
- MicroPort Scientific: ® CardioFlow Announces Leadership Transition
- MicroPort Scientific: ® Coronary Announces FireShield™ Coronary Covered Stent System Enters NMPA Special Review Procedure for Innovative Medical Devices
Follow MicroPort Scientific into a list and get an email when it puts out news.
Follow MicroPort Scientific